NCT06397066

Brief Summary

By comparing the characteristics of Helicobacter pylori (Hp) infection under magnifying endoscopy and white light endoscopy, and making judgments of Hp infection status, the advantages and disadvantages of the two endoscopic examination methods are summarized to improve the accuracy of subsequent endoscopic Hp infection status judgments.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 2, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

April 30, 2024

Last Update Submit

May 5, 2024

Conditions

Keywords

Hp infection statusmagnifying endoscopywhite light endoscopyimmunohistochemical test

Outcome Measures

Primary Outcomes (1)

  • Accuracy of different observation method

    white light endoscopy, magnifying endoscopy, and integrated endoscopic judgment to determine the status of Hp infection (including Hp current infection, Hp negative, and past H. pylori infection status)

    at the end of the observation of endoscopy procedure

Secondary Outcomes (4)

  • Sensitivity of different observation method

    at the end of the observation of endoscopy procedure

  • specificity of different observation method

    at the end of the observation of endoscopy procedure

  • result of immunohistochemistry

    the end of enrollment

  • result of breath tests.

    the end of enrollment

Study Arms (2)

the white light endoscopy group

The characteristics of white light endoscopic extraction include degree of atrophy (Kimura-Takemoto classification), congestion and edema, yellow white nodules, mucus turbidity, the arrangement of the collecting veins is regular (RAC)/irregular/disappearing, goose flesh, map-like redness, blood scabs, gastric fundus gland polyps, and scratch syndrome, and are judged according to the Kyoto Classification of Gastritis.

Procedure: White light endoscopy group

the Magnifying endoscopy group

Magnifying endoscopy(ME) uses Narrow Band Imaging (NBI)+ME to observe the non atrophic area of the gastric fundus gland. According to the proportion of the opening of the gastric fundus gland duct in one magnified field of view, it is classified as grade 1 ≤ 25%, indicating Hp current infection, 25%\<grade 2\<50%, Hp uncertain state, indicating Hp current infection or after recent sterilization, grade 3 ≥ 50%, indicating Hp non-infection or past H. pylori infection.

Procedure: Magnifying endoscopy group

Interventions

White light endoscopy observe the characteristics of mucosa under white light

the white light endoscopy group

NBI+ME to observe the non atrophic area of the gastric fundus gland. The results depend on the ratio of gastric fundus gland.

the Magnifying endoscopy group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Our endoscopy center conducts magnifying staining endoscopy examination, along with endoscopic Hp immunohistochemical testing, and cases that have recently completed carbon-13 or carbon-14 breath tests.

You may qualify if:

  • \- Our endoscopy center conducts magnifying staining endoscopy examination, along with endoscopic Hp immunohistochemical testing, and cases that have recently completed carbon-13 or carbon-14 breath tests.

You may not qualify if:

  • \- Total gastric atrophy and endoscopic type A gastritis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Hospital of Jilin University

Changchun, Jilin, 130021, China

RECRUITING

Study Officials

  • Dong Yang, doctor

    The First Hospital of Jilin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dong Yang, doctor

CONTACT

Dong Yang, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisted Investigator

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 2, 2024

Study Start

May 1, 2024

Primary Completion

December 31, 2024

Study Completion

June 30, 2025

Last Updated

May 7, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations